C10014771 / invoice 10000
Species:CANINE
Breed:West Highland White Terrier Cross
Age (years):11
Diagnosis or signs:Examination + medication
Consult notes
11/03/2026 **GAP SUMMARY** Date: 11/3/2026 Assessment: ready to start trilostaine Treatment: trilostaine 5mg x2 BID (returned stock) and cortate 5mg for emergencies Plan: RC in 2 weeks for a repeat stim 4-6 hours post meds
Animal clinical history (3 most recent)
2026-03-06T00:00:00Z 09:41:10
Post MCT R/O, Day 11 Suture Removal: History: Going well. EDDU is all normal. Exam: Surgery site looking ok. One end is a bit more scabby but healing. Sutures are removed with JC. Advised to be gentle still for another 2-3 days. Plan: Revisit with TAC regarding Cushing's
2026-02-25T00:00:00Z 16:03:42
Across the smears examined, cytological findings revealed moderate to marked red blood cell contamination accompanied by a mildly to moderately increased population of hepatocytes (which generally displayed a uniform appearance) arranged in variably sized cell clusters/clumps. Some binucleate hepatocytes were seen within some of the hepatocyte cell clusters. Some of the hepatocytes also displayed mild hydropic degeneration within their cytoplasm. A mildly increased population of non-degenerate neutrophils and small lymphocytes was also seen scattered throughout the background (particularly in one of the 2 smears examined). No obvious micro-organisms were seen. DIAGNOSIS 1) mild vacuolar (non-lipid) hepatopathy- hyperA 2) suspect nodular regenerative hyperplasia or benign hepatic neoplasm- benign change or hyperplasia 3) possible mild mixed inflammation- unsure COMMENT I could not see any obvious cytological evidence of an infective aetiopathogenesis present in the smears examined. Neither could I see any obvious cytological evidence of malignancy in the smears examined. The possibility of nodular regenerative hyperplasia could not be excluded here but was difficult to cytologically differentiate from a benign hepatic neoplasm (e.g. hepatic adenoma). The cause of the possible mild mixed cell inflammation (particularly if there is no obvious evidence of a peripheral leucocytosis) could not be definitively elucidated from the smears examined. Possible causes of hepatocellular cytoplasmic vacuolation/hydropic degeneration include metabolic/endocrine conditions as well as various types of hepatocellular injury associated with toxic insults and hypoxia. Recommend biopsy and histopathological examination for further investigation and definitive diagnosis. summary - no evidence of MCT spread - some hyperA changes - some unexplained local inflam change rec biopsy in future if ongoing concern can begin hyperA tx and have FU US in 3-6 months or if unwell *** TAC called Amanda- no msg left 4.10pm but left text of number 510 Hi Amanda I hope little Piper is doing well after her surgery. I already have the liver fine needle aspirate results for you. We see no evidence of cancer spread from the mast cell tumor and some changes which are associated with her hyperadrenal disease. There are some other cells which we aren't sure of the significance of - possibly a benign or regenerative issue and possibly some inflammation. I think we should recheck the liver with another ultrasound 3-6 months after we start with the Trilostane to treat her hyperadrenal disease. We can also so this sooner if she becomes unwell I have attached the histology here for you records. Have a lovely night and please call on Monday to chat if you have questions- I wasn't able to get through to you today. Cheers, Dr Tasha
2026-02-24T00:00:00Z 11:24:07
Staff member making call : AH Which family member spoken with: Amanda didn't answer left VM and sent SMS Recall reason: GA and lump removal Patient Report: Demeanour - eating - drinking - urine - faeces - any problems with medicating? codeine 30mg half tab BID wound/s healing OK ? appointment made for revisit ?
Previous claim history (13)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-02-23 | C09941606 | MAST CELL TUMOUR |
| 2026-02-02 | C09837366 | CUSHINGS DISEASE |
| 2026-01-14 | C09757524 | CUSHINGS DISEASE |
| 2026-01-08 | C09728530 | MAST CELL TUMOUR |
| 2026-01-08 | C09728530 | PRESENTED FOR INVESTIGATION OF ABNORMAL TEST RESULT - PRESENTING COMPLAINT |
| 2026-01-08 | C09728530 | MASS LESION - ADRENAL |
| 2026-01-05 | C09710411 | MAST CELL TUMOUR |
| 2022-05-30 | C4819360 | EAR INFECTION |
| 2022-02-25 | C4534423 | URINARY TRACT INFECTION (UTI) - BACTERIAL |
| 2022-01-12 | C4392600 | OTITIS EXTERNA |
| 2022-01-05 | C4371020 | OTITIS EXTERNA |
| 2022-01-05 | C4371020 | SEBACEOUS CYST |
| 2021-10-08 | C4158084 | CYST |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_consultation-revisit | 103.00 | 2026-03-11 | — |
| 20000 | tstarc_corticosteroids | 26.30 | 2026-03-11 | — |
| 30000 | tstarc_cushings_disease_medication | 23.00 | 2026-03-11 | — |
UPM+
- DG02293HYPERADRENOCORTICISM ("CUSHING'S")DSTP_hyperadrenocorticism_(cushing's_disease)
Variant (sleepy_king)
HYPERADRENOCORTICISM ("CUSHING's")
DSTP_hyperadrenocorticism_(cushing's_disease)
Conf: 0.890
Threshold: 0.18
Above: ✓
Correct?